Ebit تغيير تاريخ
AbbVie USD 5.65B 407M 2025-03
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amgen USD 3.6B 434M 2025-03
Arrowhead Research USD -161412000 791K 2024-12
Astellas Pharma JPY -44475000000 63.86B 2024-03
AstraZeneca USD 4.8B 604M 2025-03
Bayer EUR 855M 588M 2024-12
Biogen USD 582.8M 61.3M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Daiichi Sankyo JPY 27.08B 72.41B 2024-03
Eli Lilly USD 3.7B 1.93B 2025-03
Exelixis USD 163.46M 27.38M 2024-12
Gilead Sciences USD 2.89B 221M 2025-03
GlaxoSmithKline GBP 2.53B 1.1B 2025-03
Incyte USD 283.64M 92.62M 2025-03
Ionis Pharmaceuticals USD -146000000 36M 2025-03
Merck USD 5.22B 339M 2024-12
Moderna USD -963000000 283M 2025-03
Novartis USD 4.86B 286M 2024-12
Novartis USD 4.86B 286M 2024-12
Pfizer USD 5.93B 1.31B 2025-03
Regeneron Pharmaceuticals USD 913.7M 661M 2025-03
Roche Holding CHF 11.29B 2.68B 2024-06
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



Agios Pharmaceuticals - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.